Account
Articles
27.03.2020
NICE postpones technology appraisals

NICE confirmed that they will be prioritising work that is therapeutically critical or relates to ad...

Read more
Articles
30.01.2020
NICE EMA scientific advice

With the UKs withdrawal from the European Union, NICE’s relationship with EMA and indeed, the para...

Read more
Articles
28.05.2019
NICE scientific advice re Brexit

NICE will continue to offer joint advice with the Medicines and Healthcare products Regulatory Agenc...

Read more
News
08.04.2019
UK pharma negotiating choppy seas during Brexit

The ABPI is working closely with the Department of Health and Social Care, NHS England and NICE to e...

Read more
Articles
29.08.2018
Brexit pharmaceutical market access and the UK

With eight months left before the UK leaves the EU in March 2019, it was hoped that a clear strategy...

Read more
Articles
05.04.2017
Brexit into the pharmaceutical access unknown

Given that the UK has formally announced its decision to leave the EU, what are the implications for...

Read more
Articles
05.06.2016
Pricing and reimbursement of pharmaceuticals

Over the next two years changes to the marketing authorisation or pricing and reimbursement procedur...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.